Manufacturing mesenchymal stromal cells for phase I clinical trials

被引:41
|
作者
Hanley, Patrick J. [1 ,2 ]
Mei, Zhuyong [1 ,2 ]
Cabreira-Hansen, Maria da Graca [3 ]
Klis, Mariola [1 ,2 ]
Li, Wei [1 ,2 ]
Zhao, Yali [1 ,2 ]
Durett, April G. [1 ,2 ]
Zheng, Xingwu [4 ]
Wang, Yongping [4 ,5 ]
Gee, Adrian P. [1 ,2 ]
Horwitz, Edwin M. [4 ,5 ]
机构
[1] Texas Childrens Hosp, Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA
[2] Methodist Hosp, Houston, TX 77030 USA
[3] St Lukes Episcopal Hosp, Texas Heart Inst, Houston, TX USA
[4] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA
[5] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA
基金
美国国家卫生研究院;
关键词
clinical trials; Good Manufacturing Practices; mesenchymal stromal cells; phase I trials; BONE-MARROW; STEM-CELLS; BLOOD; CHILDREN; CULTURE; THERAPY; LIVER;
D O I
10.1016/j.jcyt.2012.09.007
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Mesenchymal stromal cells (MSCs) are multipotent progenitor cells capable of differentiating into adipocytes, osteoblasts and chondroblasts as well as secreting a vast array of soluble mediators. This potentially makes MSCs important mediators of a variety of therapeutic applications. They are actively under evaluation for immunomodulatory purposes such as graft-versus-host disease and Crohn's disease as well as regenerative applications such as stroke and congestive heart failure. We report our method of generating clinical-grade MSCs together with suggestions gathered from manufacturing experience in our Good Manufacturing Practices facility.
引用
收藏
页码:416 / 422
页数:7
相关论文
共 50 条
  • [31] Subcutaneous Injection of Allogeneic Adipose-Derived Mesenchymal Stromal Cells in Psoriasis Plaques: Clinical Trial Phase I
    Bajouri, Amir
    Dayani, Dorsa
    Sharghi, Anoushe Taj
    Karimi, Shahedeh
    Niknejadi, Maryam
    Bidgoli, Kasra Moeinabadi
    Madani, Hoda
    Kakroodi, Fatemeh Abbasi
    Blourieh, Tina
    Mardpour, Sura
    Jaroughi, Neda
    Aghdami, Nasser
    Ataie-Fashtami, Leila
    Shafiyan, Saeid
    Vosough, Massoud
    CELL JOURNAL, 2023, 25 (06) : 363 - 371
  • [32] Clinical Trials Based on Mesenchymal Stromal Cells are Exponentially Increasing: Where are We in Recent Years?
    Umberto Galderisi
    Gianfranco Peluso
    Giovanni Di Bernardo
    Stem Cell Reviews and Reports, 2022, 18 : 23 - 36
  • [33] Evaluation of Spin in Clinical Trials of Mesenchymal Stromal Cells for the Treatment of Knee Osteoarthritis: A Systematic Review
    Woolley, Katherine
    Milan, Nesa
    Master, Zubin
    Feeley, Brian T.
    AMERICAN JOURNAL OF SPORTS MEDICINE, 2025,
  • [34] Clinical Trials Based on Mesenchymal Stromal Cells are Exponentially Increasing: Where are We in Recent Years?
    Galderisi, Umberto
    Peluso, Gianfranco
    Di Bernardo, Giovanni
    STEM CELL REVIEWS AND REPORTS, 2022, 18 (01) : 23 - 36
  • [35] Good Manufacturing Practices Production of Mesenchymal Stem/Stromal Cells
    Sensebe, Luc
    Bourin, Philippe
    Tarte, Karin
    HUMAN GENE THERAPY, 2011, 22 (01) : 19 - 26
  • [36] STATISTICAL MODELING TO OPTIMIZE THE MANUFACTURING PROCESS OF MESENCHYMAL STROMAL CELLS
    Waseem, S.
    Audet, J.
    Viswanathan, S.
    OSTEOARTHRITIS AND CARTILAGE, 2019, 27 : S436 - S436
  • [37] Mesenchymal stromal cells for bone trauma, defects, and disease: Considerations for manufacturing, clinical translation, and effective treatments
    -Welch, Annie C. Bowles
    Jimenez, Angela C.
    Stevens, Hazel Y.
    Rubio, David A. Frey
    Kippner, Linda E.
    Yeago, Carolyn
    Roy, Krishnendu
    BONE REPORTS, 2023, 18
  • [38] Bone Regeneration Using Mesenchymal Stromal Cells and Biocompatible Scaffolds: A Concise Review of the Current Clinical Trials
    Re, Federica
    Borsani, Elisa
    Rezzani, Rita
    Sartore, Luciana
    Russo, Domenico
    GELS, 2023, 9 (05)
  • [39] First decade of clinical trials and published studies with mesenchymal stromal cells from umbilical cord tissue
    Couto, Pedro S.
    Shatirishvili, Gocha
    Bersenev, Alexey
    Verter, Frances
    REGENERATIVE MEDICINE, 2019, 14 (04) : 309 - 319
  • [40] Mesenchymal stromal/stem cell (MSC)-derived exosomes in clinical trials
    Ahmed Lotfy
    Noha M. AboQuella
    Hongjun Wang
    Stem Cell Research & Therapy, 14